Japanese Encephalitis News and Research

RSS
Japanese encephalitis (previously known as Japanese B encephalitis to distinguish it from von Economo's A encephalitis) is a disease caused by the mosquito-borne Japanese encephalitis virus. The Japanese encephalitis virus is a virus from the family Flaviviridae. Domestic pigs and wild birds are reservoirs of the virus; transmission to humans may cause severe symptoms. One of the most important vectors of this disease is the mosquito ''Culex tritaeniorhynchus''. This disease is most prevalent in Southeast Asia and the Far East.
Sinovac Biotech's fourth-quarter sales increase 194%

Sinovac Biotech's fourth-quarter sales increase 194%

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Parenteral Biotech to supply and distribute Sinovac Biotech's Anflu and PANFLU.1 vaccines in India

Intercell AG's revenues for full year 2009 increase 10.6%

Intercell AG's revenues for full year 2009 increase 10.6%

NanoViricides files quarterly report with Securities and Exchange Commission

NanoViricides files quarterly report with Securities and Exchange Commission

Gentel Biosciences launches integrated Proteomics Multi-System

Gentel Biosciences launches integrated Proteomics Multi-System

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

New therapeutic made from tobacco plants shown to arrest West Nile virus infection

SVA submits the first clinical trial application for HFMD vaccine in China

SVA submits the first clinical trial application for HFMD vaccine in China

Sinovac Biotech selected as Top 10 most competitive companies for 2009

Sinovac Biotech selected as Top 10 most competitive companies for 2009

Sinovac Biotech receives fourth purchase order for its H1N1 vaccine from Chinese government

Sinovac Biotech receives fourth purchase order for its H1N1 vaccine from Chinese government

Publication serves as a guide to build productive partnerships and overcome global health challenges

Publication serves as a guide to build productive partnerships and overcome global health challenges

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Sinovac Biotech receives a revised production license for its Panflu.1 vaccine

Experts gather to outline the latest creative applications of DNA barcoding

Experts gather to outline the latest creative applications of DNA barcoding

China places third purchase order for H1N1 vaccine with Sinovac Biotech

China places third purchase order for H1N1 vaccine with Sinovac Biotech

News outlets examine challenges with expanding global child immunization campaigns

News outlets examine challenges with expanding global child immunization campaigns

Research finds 50 million people vaccinated against zoonotic brain infection

Research finds 50 million people vaccinated against zoonotic brain infection

Inviragen, SingVax merge their complementary vaccine pipelines

Inviragen, SingVax merge their complementary vaccine pipelines

Sinovac Biotech announces positive results from clinical trial of H1N1 vaccine

Sinovac Biotech announces positive results from clinical trial of H1N1 vaccine

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

Intercell receives FDA approval of IXIARO, novel vaccine for Japanese encephalitis

FDA approves IXIARO for Japanese encephalitis

FDA approves IXIARO for Japanese encephalitis

Japanese encephalitis damages the brain in two ways

Japanese encephalitis damages the brain in two ways